Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
Theravance, Inc. (NASDAQ: THRX)
Sector: Medical
Current Price :
$22.02
52 Week Low
$16.39
52 Week High
$26.49
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
86M
Market Cap:
$1.78B
Avg Volume:
422891
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
Strong Up-Move After Weak Opening
Apr 02, 2012 08:00 PM |
AAPL
,
ANIK
,
AVP
,
CETV
,
EGY
,
KERX
U.S. Stocks End Higher On Upbeat Manufacturing Data; Hot Stocks: (AVP, GRPN, GPN, THRX, ESRX)
Apr 02, 2012 04:23 PM |
AEZS
,
AVP
,
ESRX
,
GPN
,
GSK
,
KERX
Glaxosmithkline (GSK) Raises Stake In Theravance (THRX) To 27 Pct
Apr 02, 2012 08:14 AM |
GSK
,
THRX
Theravance (THRX) Initiated As 'Buy' By Brean Murray, PT $24
Mar 12, 2012 11:04 AM |
THRX
On Fourth Quarter 13Fs
Mar 01, 2012 10:44 AM |
AAPL
,
ACFC
,
AMED
,
AMR
,
AMZN
,
ARII
More Articles on THRX..
Market News
More News on THRX..
Press Releases
Theravance to Present at Investor Conferences in June 2012
May 22, 2012 04:05 PM |
THRX
GlaxoSmithKline Completes Transaction to Increase Its Ownership in Theravance
May 16, 2012 09:18 AM |
THRX
Theravance to Webcast 2012 Annual Meeting of Stockholders on May 15, 2012
May 08, 2012 04:06 PM |
THRX
More Press Releases on THRX..
SEC Filings
Form 4 THERAVANCE INC For: May 15 Filed by: YOUNG WILLIAM D (10K)
May 17, 2012 07:20 PM
Form 4 THERAVANCE INC For: May 15 Filed by: WHITESIDES GEORGE M (10K)
May 17, 2012 07:19 PM
Form 4 THERAVANCE INC For: May 15 Filed by: WALTRIP WILLIAM H (10K)
May 17, 2012 07:19 PM
More SEC Filings on THRX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
THRX
Compare to S&P
YTD
-6.47 %
-16.42 %
4 Weeks
-7.06 %
-6.20 %
12 Weeks
14.07 %
12.59 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
306.67 %
EPS Growth in Last Year:
432.14 %
Sales Growth in Last Quarter:
2,270.81 %
Sales Growth in Last Quarter:
1,907.57 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##